After investigating cells with immunogenic peptide‐related mutation (HES1) and nonimmunogenic peptide‐related mutation (reticulocalbin 1, RCN1), similar situation was observed in HCC 217 that cells with immunogenic peptide‐related mutation exhibited relatively high frequency (Figure S9, Supporting Information). Here, HES1 is linked to hepatocellular carcinoma.